Hefei Hechen Biotechnology Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2022

Location

Hefei Anhui China

Primary Industry

Biotechnology

About

Established in 2022 and based in Hefei, China, Hefei Hechen Biotechnology is a synthetic biology company focusing on the development and industrialization of functional active ingredients. is a synthetic biology company focusing on the development and industrialization of functional active ingredients. The core team members of the company are from Unilever, Coca-Cola and other companies as well as Tianjin University of Science and Technology and other institutions. Among them, the company's CTO, Dr. Weizheng Zhou, is an expert in the formulation and application of functional active ingredients and was the head of Unilever's Strategic Science Research Department in China. At present, the company has two invention patent certificates. In May 2023, the company closed a round of angel+ funding. The company mainly focuses on strain technology development and industrialization application of synthetic organisms, and has now completed the construction of three platforms: SynBio Agile Development System, Highly Effective Active Ingredients Delivery and Agile BioFabrication. The core product built with the platform is L-Ergothioneine (EGT), an engineered bacterium that can effectively protect against UV damage and meet the needs of different application scenarios such as food, medicine and cosmetics.

Current Investors

Huaige Capital, Hongbo Capital, Guoyuan Innovating Investment Co., Ltd.

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Biotechnology, Biomaterials

Website

www.hcbioworkx.com

Company Stage

Angel & Seed

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.